FDA Approves Diabetes Drug for Kids 8 and Up

The FDA just approved teplizumab for children aged 8 and older with stage 3 type 1 diabetes, expanding treatment options for young patients.

This marks an important step forward in managing a disease that affects over 300,000 American children.